High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8

Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer

(2020) Eric C. Cheung et al.   CANCER CELL

Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient

(2020) Banchob Sripa et al.   Human Cell

The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism

(2019) Soojeong Chang et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1

(2018) Chatchai Phoomak et al.   ONCOGENE

ROS signalling in the biology of cancer

(2018) Jennifer N. Moloney et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

The Warburg Effect in Diabetic Kidney Disease

(2018) Guanshi Zhang et al.   SEMINARS IN NEPHROLOGY

Licochalcone A from licorice root, an inhibitor of human hepatoma cell growth via induction of cell apoptosis and cell cycle arrest

(2018) Jun Wang et al.   FOOD AND CHEMICAL TOXICOLOGY

Interactome mapping defines BRG1, a component of the SWI/SNF chromatin remodeling complex, as a new partner of the transcriptional regulator CTCF

(2018) Maria Michela Marino et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Reactive oxygen species and cancer paradox: To promote or to suppress?

(2017) Sehamuddin Galadari et al.   FREE RADICAL BIOLOGY AND MEDICINE

High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation

(2017) Chatchai Phoomak et al.   Scientific Reports

Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways

(2016) Lei Cao et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells

(2016) Luis Antonio Flores-López et al.   CELLULAR ONCOLOGY

High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation

(2016) Charupong Saengboonmee et al.   Scientific Reports

Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma

(2015) Charupong Saengboonmee et al.   Cancer Epidemiology

The Chromatin Remodeler CHD8 Is Required for Activation of Progesterone Receptor-Dependent Enhancers

(2015) María Ceballos-Chávez et al.   PLoS Genetics

Diabetes mellitus: influences on cancer risk

(2014) Leszek Szablewski   DIABETES-METABOLISM RESEARCH AND REVIEWS

Oncogenic functions of the transcription factor Nrf2

(2013) Irene Gañán-Gómez et al.   FREE RADICAL BIOLOGY AND MEDICINE

Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production

(2013) X Yuan et al.   Cell Death & Disease

Oxidative stress and cancer: An overview

(2012) Venus Sosa et al.   AGEING RESEARCH REVIEWS

Diabetes mellitus and cancer risk: Review of the epidemiological evidence

(2012) Kentaro Shikata et al.   CANCER SCIENCE

Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common Cancers

(2012) Gaurav Aggarwal et al.   PANCREAS

Diabetes mellitus and increased risk of cholangiocarcinoma

(2011) Wei Jing et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Cholangiocarcinoma: principles and current trends

(2011) George N Zografos et al.   Hepatobiliary & Pancreatic Diseases International

Signal transduction by reactive oxygen species

(2011) Toren Finkel   JOURNAL OF CELL BIOLOGY

Diabetes and Cancer: Is Diabetes Causally Related to Cancer?

(2011) Sunghwan Suh et al.   Diabetes & Metabolism Journal

Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos

(2010) Banchob Sripa et al.   ACTA TROPICA

Regulation of Androgen-Responsive Transcription by the Chromatin Remodeling Factor CHD8

(2010) Tushar Menon et al.   MOLECULAR ENDOCRINOLOGY

Epidemiology of cholangiocarcinoma: An update focusing on risk factors

(2009) Hai-Rim Shin et al.   CANCER SCIENCE

Diabetes and cancer

(2009) Paolo Vigneri et al.   ENDOCRINE-RELATED CANCER

CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis

(2009) Masaaki Nishiyama et al.   NATURE CELL BIOLOGY

The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene

(2009) M. Rodríguez-Paredes et al.   NUCLEIC ACIDS RESEARCH

CHD8 Is an ATP-Dependent Chromatin Remodeling Factor That Regulates  -Catenin Target Genes

(2008) B. A. Thompson et al.   MOLECULAR AND CELLULAR BIOLOGY

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma

(2008) S.A. Khan et al.   HPB